<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Stock Analysis: Becton Dickinson &amp; Co (BDX) *</title>
	<atom:link href="http://dividendsvalue.com/1489/stock-analysis-becton-dickinson-co-bdx/feed/" rel="self" type="application/rss+xml" />
	<link>http://dividendsvalue.com/1489/stock-analysis-becton-dickinson-co-bdx/</link>
	<description>Dividend Investing &#38; Value Investing For A Superior Portfolio</description>
	<lastBuildDate>Mon, 11 Apr 2011 13:45:49 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
	<item>
		<title>By: Nurseb911</title>
		<link>http://dividendsvalue.com/1489/stock-analysis-becton-dickinson-co-bdx/comment-page-1/#comment-2778</link>
		<dc:creator>Nurseb911</dc:creator>
		<pubDate>Wed, 03 Dec 2008 13:29:00 +0000</pubDate>
		<guid isPermaLink="false">http://dividendsvalue.com/1489/stock-analysis-becton-dickinson-co-bdx/#comment-2778</guid>
		<description>I certainly agree with your assessment D4L.  I disclosed recently that I initiated a position in the company to compliment my long-term holding in BAX.  Both are excellent companies with strong histories of raising their dividends.&lt;br/&gt;I work with both of their products on a daily basis and their R&amp;D divisions are very well run with innovative products.  I think if investors want exposure to healthcare without the threat of patents issues in big pharma that these two stocks offer excellent exposure.</description>
		<content:encoded><![CDATA[<p>I certainly agree with your assessment D4L.  I disclosed recently that I initiated a position in the company to compliment my long-term holding in BAX.  Both are excellent companies with strong histories of raising their dividends.<br />I work with both of their products on a daily basis and their R&amp;D divisions are very well run with innovative products.  I think if investors want exposure to healthcare without the threat of patents issues in big pharma that these two stocks offer excellent exposure.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

